Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September, 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Titan Biotech Limited on 6ix
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Sep 29 2025
- Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
- Titan Biotech Limited Press Release Sep 27 2025
- Announcement under Regulation 30 (LODR)-Change in Management
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Later from Titan Biotech
- Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025.
- Titan Biotech Limited Press Release Nov 04 2025
- Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025
- Titan Biotech Limited Press Release Nov 11 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech